Related Experiment Video
Updated: Jul 5, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia
Arthur A M Wilde1, Zahurul A Bhuiyan, Lia Crotti
1University of Amsterdam, Amsterdam. a.a.wilde@amc.uva.nl
Catecholaminergic polymorphic ventricular tachycardia (CPVT) can be life-threatening. Surgical left cardiac sympathetic denervation effectively eliminated arrhythmias in three young adults, offering a promising long-term treatment option.
Area of Science:
- Cardiology
- Autonomic Nervous System Research
- Pediatric Arrhythmia Management
Background:
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe genetic disorder causing dangerous heart rhythms, primarily in children and adolescents.
- Standard treatment with beta-blockers is insufficient for some patients, necessitating implantable cardioverter-defibrillators (ICDs).
- ICD shocks in CPVT patients can paradoxically induce further arrhythmias, creating a cycle of electrical storm.
Observation:
- This study reports on three young adults diagnosed with CPVT who experienced persistent symptoms despite conventional therapies.
- These individuals had previously undergone treatment with beta-blockers and ICD implantation.
- The patients presented with a history of frequent, life-threatening ventricular arrhythmias.
Findings:
- Surgical left cardiac sympathetic denervation was performed on all three patients.
- Following the denervation procedure, all patients became symptom-free.
- Long-term follow-up demonstrated sustained efficacy of the surgical intervention in preventing arrhythmias.
Implications:
- Left cardiac sympathetic denervation presents a viable and effective long-term therapeutic strategy for select CPVT patients.
- This surgical approach may reduce the need for ICDs or mitigate the risk of ICD-related complications in CPVT.
- Further research into the role of autonomic modulation in managing CPVT is warranted.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Cardiomyopathy V: Interprofessional Care

